Background Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. Methods We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling. Results Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most ...
Interrogation of hematopoietic tissue at the clonal level has a rich history spanning over 50 years,...
Clonal hematopoiesis (CH) has been recognized as a predisposing factor for the development of myeloi...
Clonal hematopoiesis (CH) is a common aging-associated condition with increased risk of hematologic ...
Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages...
Background The incidence of hematologic cancers increases with age. These cancers are associated wit...
BACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated wi...
Acquired mutations are pervasive across normal tissues. However, understanding of the processes that...
SummaryClonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Clonal hematopoiesis (CH), defined as the clonal expansion of mutated hematopoietic stem and progeni...
Knowledge about evolution of clonal hematopoiesis, which may drive malignant progression, is crucial...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Clonal hematopoiesis (CH), characterized by a fraction of peripheral blood cells carrying an acquire...
Age is the dominant risk factor for most chronic human diseases, but the mechanisms through which ag...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Interrogation of hematopoietic tissue at the clonal level has a rich history spanning over 50 years,...
Clonal hematopoiesis (CH) has been recognized as a predisposing factor for the development of myeloi...
Clonal hematopoiesis (CH) is a common aging-associated condition with increased risk of hematologic ...
Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages...
Background The incidence of hematologic cancers increases with age. These cancers are associated wit...
BACKGROUND: The incidence of hematologic cancers increases with age. These cancers are associated wi...
Acquired mutations are pervasive across normal tissues. However, understanding of the processes that...
SummaryClonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Clonal hematopoiesis (CH), defined as the clonal expansion of mutated hematopoietic stem and progeni...
Knowledge about evolution of clonal hematopoiesis, which may drive malignant progression, is crucial...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Clonal hematopoiesis (CH), characterized by a fraction of peripheral blood cells carrying an acquire...
Age is the dominant risk factor for most chronic human diseases, but the mechanisms through which ag...
Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a bloo...
Interrogation of hematopoietic tissue at the clonal level has a rich history spanning over 50 years,...
Clonal hematopoiesis (CH) has been recognized as a predisposing factor for the development of myeloi...
Clonal hematopoiesis (CH) is a common aging-associated condition with increased risk of hematologic ...